Product Program year 2021 Source: CMS Open Payments

Guideliner V3 Catheter

Device Interventional Access

PDI 10841156100605

Open in the dashboard

General payments

$27,500

79 payments

Research payments

$0

0 payments

Through program year 2021, $27,500 in general payments and $0 in research payments were reported against Guideliner V3 Catheter (Interventional Access).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $27,500 79

Breakdown

Who paid General payments · program year 2021
  1. Teleflex LLC $18,827 67 payments
  2. Arrow International, Inc. $4,048 8 payments
  3. Arrow Interventional, Inc. $3,250 2 payments
  4. Vascular Solutions, Inc. $1,375 2 payments
Top recipients General payments · program year 2021
  1. Garrett Wong Cardiovascular Disease · Sacramento, CA $7,861 29% · 2 payments
  2. Lorenzo Azzalini Interventional Cardiology · Seattle, WA $7,265 26% · 5 payments
  3. Taral Patel Interventional Cardiology · Scottsdale, AZ $5,482 20% · 8 payments
  4. Emmanouil Brilakis Interventional Cardiology · Minneapolis, MN $4,050 15% · 2 payments
  5. David Kandzari Interventional Cardiology · Atlanta, GA $1,000 4% · 1 payment

The top 5 of 60 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Interventional Cardiology Internal Medicine $18,810 68% · 25 practitioners
  2. Cardiovascular Disease Internal Medicine $8,439 31% · 20 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $46 <1% · 2 practitioners
  4. Nurse Practitioner $32 <1% · 2 practitioners
  5. Vascular Surgery Surgery $29 <1% · 2 practitioners

The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. California $7,886 29% · 2 recipients
  2. New York $7,289 27% · 2 recipients
  3. Tennessee $5,562 20% · 6 recipients
  4. Minnesota $4,050 15% · 1 recipient
  5. Georgia $1,289 5% · 3 recipients

The top 5 of 23 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

79 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record